The S&P/ASX All Ordinaries Index (ASX: XAO) is deep in the red today after a hot US inflation report sent Wall Street into a tailspin overnight.
At the time of writing, the All Ords index has slipped 2.6% to 7,065 points. The S&P/ASX 200 Index (ASX: XJO) is mirroring this fall, also sliding 2.6% to 6,825 points.
But amongst the sea of red, some ASX All Ords shares are shining brightly. Let's take a look.
Peter Warren Automotive Holdings Ltd (ASX: PWR)
The Peter Warren share price is racing higher today after the car dealership company revealed it has a new major shareholder.
At the time of writing, Peter Warren shares have zoomed 13.9% higher to $2.87.
According to an initial substantial holder notice, SMA Motors splashed $50 million yesterday to pick up a 9% stake in PWR.
In a separate notice, the seller is revealed to be Quadrant Private Equity, offloading 15.7 million PWR shares off-market to SMA at an average price of roughly $3.19 per share.
This represents a sizeable 26% premium to PWR's closing price yesterday of $2.52.
As my Fool colleague James reported this morning, SMA Motors is the name behind Suttons Motors, one of Sydney's largest car dealership groups.
Clover Corporation Limited (ASX: CLV)
Food technology business Clover is also defying the market sell-off today, surging 11.1% at the time of writing to $1.10.
The ASX All Ords share handed in its FY22 results this morning, reporting double-digit sales and profit growth.
Clover delivered net revenue of $70.7 million, up 17% from the prior year and at the top end of guidance.
In the second half of the year, sales rebounded across all of Clover's regions as key infant formula manufacturer order volumes lifted and international borders opened.
However, Clover hasn't been spared from rising inflation. It experienced pressure on milk proteins, freight costs, and other ingredients throughout the year, which impacted margins.
On the bottom line, the company reported a net profit after tax (NPAT) of $7.1 million, growing 19% from FY21.
Clover also doubled its final dividend to 1 cent per share, fully franked. This puts Clover shares on a trailing dividend yield of 1.4%.
Avita Medical Inc (ASX: AVH)
Last but not least, regenerative medicine company Avita is staging a comeback today.
The Avita share price was crunched when the company released its FY22 results in mid-August.
But its fortunes have turned today as Avita shares are currently printing a 3.9% gain to sit at $2.
The ASX All Ords share hasn't come out with any news today. But yesterday, it announced positive topline trial results.
These results relate to a pivotal, randomised, controlled trial evaluating the safety and effectiveness of Avita's Recell System for the repigmentation of stable vitiligo lesions.
Results showed that 56% of Recell treatments led to repigmentation of more than 50% of the treated area. The control group managed only 12% using the typical first-line treatment for vitiligo.
Meanwhile, 36% of Recell treatments resulted in repigmentation of at least 80% of the treated area compared to 0% for the control treatment.
